Xalatan (Latanoprost) - Summary

XALATAN SUMMARY

Xalatan^®
latanoprost ophthalmic solution
0.005% (50 µg/mL)

Latanoprost is a prostaglandin F_2(alpha) analogue. Latanoprost is a prostanoid selective FP receptor agonist that is believed to reduce the intraocular pressure (IOP) by increasing the outflow of aqueous humor.

XALATAN Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

See all Xalatan indications & dosage >>

XALATAN NEWS HIGHLIGHTS

Published Studies Related to Xalatan (Latanoprost)

Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma. [2008.10]

Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma. [2008.09]

Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: a patient-use study. [2008.06.11]

Efficacy of latanoprost when stored at room temperature. [2008.06]

Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects. A crossover study. [2008.05]

more >>

Clinical Trials Related to Xalatan (Latanoprost)

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). [Completed]

Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata [Active, not recruiting]

Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% [Completed]

Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study [Active, not recruiting]

24-Hour IOP Control With Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combination in Open-Angle Glaucoma [Completed]

more >>